Structural brain MRI studies in autism spectrum disorder

por Petrović, J. M., Binic, I., Stojanovic, A., Zdravkovic, M., Petrovic, F.
Publicado 2023

Cognitive behavioral therapy for patients with schizophrenia

por Binic, I., Petrovic, J., Antonijevic, J., Pancic, D., Zdravkovic, M., Petrovic, F.
Publicado 2023

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

por Courrèges, J-P, Vilsbøll, T, Zdravkovic, M, Le-Thi, T, Krarup, T, Schmitz, O, Verhoeven, R, Bugáñová, I, Madsbad, S
Publicado 2008

P951: CLINICAL AND LABORATORY CHARACTERISTICS, COURSE AND OUTCOME OF COVID19 INFECTION IN PATIENTS WITH MULTIPLE MYELOMA

por Sretenovic, A., Mitrovic, M., Adzic Vukicevic, T., Bukumiric, Z., Markovic, O., Zdravkovic, M., Antic, D., Bila, J.
Publicado 2022

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

por Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R.
Publicado 2009

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitaz...

por Marre, M, Shaw, J, Brändle, M, Bebakar, W M W, Kamaruddin, N A, Strand, J, Zdravkovic, M, Le Thi, T D, Colagiuri, S
Publicado 2009

The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study

por Gajic, I., Jovicevic, M., Popadic, V., Trudic, A., Kabic, J., Kekic, D., Ilic, A., Klasnja, S., Hadnadjev, M., Popadic, D.J., Andrijevic, A., Prokic, A., Tomasevic, R., Ranin, L., Todorovic, Z., Zdravkovic, M., Opavski, N.
Publicado 2023